ten Bosch John Roderick 4
4 · BillionToOne, Inc. · Filed Jul 15, 2026
Research Summary
AI-generated summary of this filing
BillionToOne (BLLN) SVP John R. ten Bosch Sells 4,251 Shares
What Happened
- John R. ten Bosch, Senior Vice President of Laboratory Operations at BillionToOne (BLLN), reported three sales on 2026-07-13, disposing of a total of 4,251 shares (3 x 1,417 shares) at $125.46 per share. Each block generated $177,777, for aggregate proceeds of approximately $533,331. The transactions are reported as open-market or private sales (code S).
Key Details
- Transaction date: July 13, 2026
- Price per share: $125.46
- Shares sold: 3 transactions of 1,417 shares each; total 4,251 shares
- Total proceeds: ~$533,331 (3 × $177,777)
- Shares owned after transaction: Not specified in the provided Form 4
- Filing: Form 4 filed July 15, 2026 (two business days after the trades)
- Footnote: Transactions were made under a Rule 10b5-1 trading plan adopted March 6, 2026
Context
- These are sales (not purchases) and were executed under a pre-established 10b5-1 plan, which typically indicates pre-planned, systematic disposition rather than an opportunistic trade. The filing appears timely (filed within the usual two-business-day window for Form 4).
Insider Transaction Report
Form 4
ten Bosch John Roderick
SVP of Laboratory Operations
Transactions
- Sale
Class A Common Stock
[F1]2026-07-13$125.46/sh−1,417$177,777→ 32,135 total - Sale
Class A Common Stock
[F1]2026-07-13$125.46/sh−1,417$177,777→ 30,718 total - Sale
Class A Common Stock
[F1]2026-07-13$125.46/sh−1,417$177,777→ 29,301 total
Footnotes (1)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-07-15